WallStSmart

Accenture plc (ACN)vsIBEX Ltd (IBEX)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Accenture plc generates 11402% more annual revenue ($72.11B vs $626.95M). ACN leads profitability with a 10.6% profit margin vs 7.5%. IBEX trades at a lower P/E of 9.4x. ACN earns a higher WallStSmart Score of 62/100 (C+).

ACN

Buy

62

out of 100

Grade: C+

Growth: 4.7Profit: 7.0Value: 6.7Quality: 6.5
Piotroski: 3/9Altman Z: 2.79

IBEX

Buy

61

out of 100

Grade: C+

Growth: 6.7Profit: 7.0Value: 6.7Quality: 7.5
Piotroski: 5/9Altman Z: 3.62
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

ACNUndervalued (+10.0%)

Margin of Safety

+10.0%

Fair Value

$198.11

Current Price

$178.25

$19.86 discount

UndervaluedFair: $198.11Overvalued

Intrinsic value data unavailable for IBEX.

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

ACN5 strengths · Avg: 8.6/10
Market CapQuality
$114.61B9/10

Large-cap with strong market position

Return on EquityProfitability
24.6%9/10

Every $100 of equity generates 25 in profit

Debt/EquityHealth
0.279/10

Conservative balance sheet, low leverage

P/E RatioValuation
15.3x8/10

Attractively priced relative to earnings

Free Cash FlowQuality
$3.67B8/10

Generating 3.7B in free cash flow

IBEX6 strengths · Avg: 8.8/10
P/E RatioValuation
9.4x10/10

Attractively priced relative to earnings

Altman Z-ScoreHealth
3.6210/10

Safe zone — low bankruptcy risk

Return on EquityProfitability
29.3%9/10

Every $100 of equity generates 29 in profit

Price/BookValuation
2.5x8/10

Reasonable price relative to book value

Revenue GrowthGrowth
16.8%8/10

16.8% revenue growth

EPS GrowthGrowth
21.9%8/10

Earnings expanding 21.9% YoY

Areas to Watch

ACN2 concerns · Avg: 3.5/10
EPS GrowthGrowth
4.0%4/10

4.0% earnings growth

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

IBEX2 concerns · Avg: 3.0/10
Market CapQuality
$400.87M3/10

Smaller company, higher risk/reward

Profit MarginProfitability
7.5%3/10

7.5% margin — thin

Comparative Analysis Report

WallStSmart Research

Bull Case : ACN

The strongest argument for ACN centers on Market Cap, Return on Equity, Debt/Equity. PEG of 1.38 suggests the stock is reasonably priced for its growth.

Bull Case : IBEX

The strongest argument for IBEX centers on P/E Ratio, Altman Z-Score, Return on Equity. Revenue growth of 16.8% demonstrates continued momentum.

Bear Case : ACN

The primary concerns for ACN are EPS Growth, Piotroski F-Score.

Bear Case : IBEX

The primary concerns for IBEX are Market Cap, Profit Margin.

Key Dynamics to Monitor

ACN profiles as a value stock while IBEX is a growth play — different risk/reward profiles.

ACN carries more volatility with a beta of 1.07 — expect wider price swings.

IBEX is growing revenue faster at 16.8% — sustainability is the question.

ACN generates stronger free cash flow (3.7B), providing more financial flexibility.

Bottom Line

ACN scores higher overall (62/100 vs 61/100). Both earn "Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Accenture plc

TECHNOLOGY · INFORMATION TECHNOLOGY SERVICES · USA

Accenture plc is an Irish-domiciled multinational company that provides consulting and processing services. It has been incorporated in Dublin, Ireland since 2009.

IBEX Ltd

TECHNOLOGY · INFORMATION TECHNOLOGY SERVICES · USA

IBEX Limited provides comprehensive technology-enabled customer lifecycle experience solutions in the United States and internationally.

Visit Website →

Want to dig deeper into these stocks?